Expertise in
1
conditions

Sebastian M. Schmid

Ratzeburger Allee 160, 
Luebeck, SH, DE 
Expertise in
1
conditions
Ratzeburger Allee 160, 
Luebeck, SH, DE 

Overview

Sebastian Schmid practices practicing medicine in Luebeck, Germany.

Mr. Schmid is highly rated in 1 condition, according to our data. His clinical expertise encompasses Obesity, Ballinger-Wallace Syndrome, Diabetic Ketoacidosis, Diabetic Hyperglycemic Hyperosmolar Syndrome, and Gastric Bypass.

He is actively involved in clinical research, co-authoring 64 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Ratzeburger Allee 160, Luebeck, SH 23538, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

PARADIGHM (Physicians Advancing Disease Knowledge in Hypoparathyroidism): A Registry for Patients With Chronic Hypoparathyroidism
PARADIGHM (Physicians Advancing Disease Knowledge in Hypoparathyroidism): A Registry for Patients With Chronic Hypoparathyroidism
Enrollment Status: Completed
Publish Date: July 14, 2026
Intervention Type: Other
The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
Enrollment Status: Completed
Publish Date: July 08, 2026
Intervention Type: Drug
Study Drugs: Tirzepatide, Dulaglutide
Study Phase: Phase 3
View 1 Less Clinical Trial

64 Total Publications

Real-world data of 12-month adjunct sodium-glucose co-transporter-2 inhibitor treatment in type 1 diabetes from the German/Austrian DPV registry: Improved HbA1c without diabetic ketoacidosis.
Real-world data of 12-month adjunct sodium-glucose co-transporter-2 inhibitor treatment in type 1 diabetes from the German/Austrian DPV registry: Improved HbA1c without diabetic ketoacidosis.
Journal: Diabetes, obesity & metabolism
Published: September 03, 2021

Frequently Asked Questions about Sebastian M. Schmid

Is Sebastian M. Schmid a top-rated expert for Obesity?

MediFind is an objective health platform that identifies experts based on real-world data. Sebastian M. Schmid is classified as an Advanced expert for Obesity, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Sebastian M. Schmid participate in research or clinical trials?

Yes. Sebastian M. Schmid has published 64 articles and abstracts on conditions like Obesity. You can view a list of Sebastian M. Schmid's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Schmid's expertise for a condition
ConditionClose
      View All 14 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile